PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells

Current Cancer Drug Targets

Volumn 9, Issue 4, 2009, Pages 500-509

  Ding, Jin ^a,b   Ning, Beifang ^b   Huang, Yi ^c   Zhang, Dongyun ^a   Li, Jingxia ^a   Chen, Chang Yan ^c   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Akt; Arsenite; c Jun; Cell proliferation; Cyclin D1; JNK; PI 3K

Indexed keywords

ARSENIC TRIOXIDE; CYCLIN D1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B BETA; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BRONCHUS MUCOSA; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE LOSS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REPORTER GENE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ARSENITES; BRONCHI; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-JUN; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 67649337506     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909788486740     Document Type: Article

References (52)

1. Chappell, W. R.; Beck, B. D.; Brown, K. G.; Chaney, R.; Cothern, R.; Cothern, C. R. Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ. Health Perspect. 1997, 105, 1060-1067. (Pubitemid 28134983)
2. Knowles, F. C.; Benson, A. A. The enzyme inhibitory form of inorganic arsenic. Z Gesamte Hyg. 1984, 30, 625-626. (Pubitemid 15188598)
3. Bettley, F. R.; O'Shea, J. A. The absorption of arsenic and its relation to carcinoma. Br. J. Dermatol. 1975, 92, 563-568.
4. Landolph, J. R. Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds. Environ. Health Perspect. 1994, 102(Suppl. 3), 119-125. (Pubitemid 24316370)
5. Hernández-Zavala, A.; Córdova, E.; Del Razo, L. M.; Cebrián, M. E.; Garrido, E. Effects of arsenite on cell cycle progression in a human bladder cancer cell line. Toxicology 2005, 1, 49-57. (Pubitemid 39601685)
6. Winston, J. T.; Pledger, W. J. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol. Biol. Cell. 1993, 4, 1133-1144. (Pubitemid 24007576)
7. Barnes, D. M.; Gillett, C. E. Cyclin D1 in breast cancer. Breast Cancer Res. Treat. 1998, 52(1-3), 1-15. (Pubitemid 29056081)
8. Worsley, S. D.; Ponder, B. A.; Davies, B. R. Over expression of cyclin D1 in epithelial ovarian cancers. Gynecol. Oncol. 1997, 64, 189-1895.
9. Michalides, R.; Hageman, P.; van Tinteren, H.; Houben, L.; Wientjens, E.; Klompmaker, R. A clinicopathological study on over expression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer 1996, 73, 728-734. (Pubitemid 26105298)
10. Proctor, A. J.; Coombs, L. M.; Cairns, J. P.; Knowles, M. A. Amplification at chromosome 11q13 in transitional cell tumors of the bladder. Oncogene 1991, 6, 789-795. (Pubitemid 21924152)
11. Burnworth, B.; Popp, S.; Stark, H. J.; Steinkraus, V.; Bröcker, E. B.; Hartschuh, W.; Birek, C.; Boukamp, P. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 2006, 25, 4399-4412. (Pubitemid 44141628)
12. Sauter, E. R.; Nesbit, M.; Litwin, S.; Klein-Szanto, A. J.; Cheffetz, S.; Herlyn, M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res. 1999, 59, 4876-4881. (Pubitemid 29472891)
13. Arber, N.; Doki, Y.; Han, E. K.; Sgambato, A.; Zhou, P.; Kim, N. H. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 1997, 57, 1569-1574. (Pubitemid 27175576)
14. Baldin, V.; Lukas, J.; Marcote, M. J.; Pagano, M.; Draetta, G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993, 7, 812-821. (Pubitemid 23163585)
15. Ouyang, W.; Ma, Q.; Li, J.; Zhang, D.; Liu, Z. G.; Rustgi, A. K.; Huang, C. Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res. 2005, 65, 9287-9293. (Pubitemid 41507995)
16. Ouyang, W.; Li, J.; Ma, Q.; Huang, C. Essential roles of I-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis 2006, 27(4), 864-873.
17. Yan, Y. X.; Nakagawa, H.; Lee, M. H.; Rustgi, A. K. Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter. J. Biol. Chem. 1997, 272, 33181-33190. (Pubitemid 28023664)
18. Vogt, B. L.; Rossman, T. G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - a possible mechanism for arsenite's comutagenicity. Mutat. Res. 2001, 478, 159-168. (Pubitemid 32530861)
19. Hinz, M.; Krappmann, D.; Eichten, A.; Heder, A.; Scheidereit, C.; Strauss, M. NF-κB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell Biol. 1999, 19, 2690-2698. (Pubitemid 29144513)
20. Lee, R. J.; Albanese, C.; Fu, M.; D'Amico, M.; Lin, B.; Watanabe, G.; Haines, G. K. 3rd; Siegel, P. M.; Hung, M. C.; Yarden, Y.; Horowitz, J. M.; Muller, W. J.; Pestell, R. G. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Mol. Cell Biol. 2000, 20, 672-683.
21. Watanabe, G.; Albanese, C.; Lee, R. J.; Reutens, A.; Vairo, G.; Henglein, B.; Pestell, R. G. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol. Cell Biol. 1998, 18, 3212-3222. (Pubitemid 28240494)
22. Lee, R. J.; Albanese, C.; Stenger, R. J.; Watanabe, G.; Inghirami, G.; Haines, G. K.; Webster, M.; Muller, W. J.; Brugge, J. S.; Davis, R. J.; Pestell, R. G. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J. Biol. Chem. 1999, 274, 7341-7350. (Pubitemid 129505027)
23. Matsumura, I.; Kitamura, T.; Wakao, H.; Tanaka, H.; Hashimoto, K.; Albanese, C.; Downward, J.; Pestell, R. G.; Kanakura, Y. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 1999, 18, 1367-1377. (Pubitemid 29110320)
24. Ding, J.; Zhang, R.; Li, J.; Xue, C.; Huang, C. Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells. Mol. Cell Biochem. 2006, 287, 117-125. (Pubitemid 44057399)
25. Ding, J.; Li, J.; Xue, C.; Wu, K.; Ouyang, W.; Zhang, D.; Yan, Y.; Huang, C. Cyclooxygenase-2 Induction by Arsenite Is through a Nuclear Factor of Activated T-cell-dependent Pathway and Plays an Antiapoptotic Role in Beas-2B Cells. J. Biol. Chem. 2006, 281, 24405-24413. (Pubitemid 44274213)
26. Dérijard, B.; Hibi, M.; Wu, I. H.; Barrett, T.; Su, B.; Deng, T.; Karin, M.; Davis, R. J. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76, 1025-1037. (Pubitemid 24106383)
27. Huang, C.; Ma, W. Y.; Young, M. R.; Colburn, N.; Dong, Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl. Acad. Sci. USA 1998, 95, 156-161. (Pubitemid 28103923)
28. Sasaki, T.; Wada, T.; Kishimoto, H.; Irie-Sasaki, J.; Matsumoto, G.; Goto, T.; Yao, Z.; Wakeham, A.; Mak, T. W.; Suzuki, A.; Cho, S. K.; Zuniga-Pflucker, J. C.; Oliveira-dos-Santos, A. J.; Katada, T.; Nishina, H.; Penninger, J. M. The stress kinase mitogen-activated protein kinase kinase (MKK)7 is a negative regulator of antigen receptor and growth factor receptor-induced proliferation in hematopoietic cells. J. Exp. Med. 2001, 194(6), 757-768. (Pubitemid 32983012)
29. Mielke, K.; Herdegen, T. JNK and p38 stresskinases - degenerative effectors of signal-transduction-cascades in the nervous system. Prog. Neurobiol. 2000, 61, 45-60. (Pubitemid 30100402)
30. Haga, S.; Ogawa, W.; Ozaki, M. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J. Hepatol. 2005, 43(5), 799-807. (Pubitemid 41414505)
31. Li, J.; Chen, H.; Tang, M. S.; Shi, X.; Amin, S.; Desai, D.; Costa, M.; Huang, C. PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells. J. Cell Biol. 2005, 165, 77-86.
32. Kastan, M. B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 2004, 432, 316-323. (Pubitemid 39551659)
33. Stacey, D. W. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr. Opin. Cell Biol. 2003, 15, 158-163. (Pubitemid 36332190)
34. Semczuk, A.; Jakowicki, J. A. Alterations of pRb1-cyclin D1-cdk4/6-p16INK4A pathway in endometrial carcinogenesis. Cancer Lett. 2003, 203, 1-12.
35. Ouyang, W.; Luo, W.; Zhang, D.; Jian, J.; Ma, Q.; Li, J.; Shi, X.; Chen, J.; Gao, J.; Huang, C. PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation. Environ Health Perspect. 2008, 116, 1-6.
36. Ouyang, W.; Li, J.; Zhang, D.; Jiang, B. H.; Huang, D. C. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1. J. Cell. Biochem. 2007, 101, 969-978. (Pubitemid 47040876)
37. Huang, C.; Ma, W. Y.; Li, J.; Goranson, A.; Dong, Z. Requirement of Erk, but Not JNK, for Arsenite-induced Cell Transformation. J. Biol. Chem. 1999, 274, 14595-14601. (Pubitemid 129518782)
38. Kim, J. Y.; Choi, J. A.; Kim, T. H.; Yoo, Y. D.; Kim, J. I.; Lee, Y. J.; Yoo, S. Y.; Cho, C. K.; Lee, Y. S.; Lee, S. J. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J. Cell Phys. 2002, 190, 29-37. (Pubitemid 33116288)
39. Arteel, G. E.; Guo, L.; Schlierf, T.; Beier, J. I.; Kaiser, J. P.; Chen, T. S.; Liu, M.; Conklin, D. J.; Miller, H. L.; von Montfort, C.; States, J. C. Subhepatotoxic exposure to arsenic enhances lipopolysaccharide- induced liver injury in mice. Toxicol. Appl. Pharm. 2008, 226, 128-139. (Pubitemid 350297340)
40. Lehmann, G. M.; McCabe, M. J. Jr. Arsenite slows S phase progression via inhibition of cdc25A dual specificity phosphatase gene transcription. Toxicol. Sci. 2007, 99, 70-78. (Pubitemid 47250368)
41. Liao, W. T.; Lin, P.; Cheng, T. S.; Yu, H. S.; Chang, L. W. Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells. Toxicol. Appl. Pharma. 2007, 225, 162-170. (Pubitemid 350103715)
42. Watanabe, G.; Lee, R. J.; Albanese, C.; Rainey, W. E.; Batlle, D.; Pestell, R. G. Angiotensin II activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 1996, 271, 22570-22577. (Pubitemid 26304696)
43. Zhang, X; Jin, B.; Huang, C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr. Cancer Drug Targets 2007, 7, 305-316. (Pubitemid 46849235)
44. Nagata, D.; Suzuki, E.; Nishimatsu, H.; Satonaka, H.; Goto, A.; Omata, M.; Hirata, Y. Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells. J. Biol. Chem. 2001, 276, 662-669. (Pubitemid 32050363)
45. Sabapathy, K.; Hochedlinger, K.; Nam, S. Y.; Bauer, A.; Karin, M.; Wagner, E. F. Distinct Roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell. 2004, 15, 713-725. (Pubitemid 39194902)
46. Sabapathy, K.; Kallunki, T.; David, J. P.; Graef, I.; Karin, M.; Wagner, E. F. c-Jun NH2-Terminal Kinase (JNK)1 and JNK2 Have Similar and Stage-dependent Roles in Regulating T Cell Apoptosis and Proliferation. J. Exp. Med. 2001, 193, 317-328. (Pubitemid 32524515)
47. Hochedlinger, K.; Wagner, E. F.; Sabapathy, K. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis. Oncogene 2002, 21, 2441-2445. (Pubitemid 34407304)
48. Brunet, A.; Datta, S. R.; Greenberg, M. E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 2001, 11, 297-305.
49. Ozes, O. N.; Mayo, L. D.; Gustin, J. A.; Pfeffer, S. R.; Pfeffer, L. M.; Donner, D. B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401, 82-85. (Pubitemid 29418447)
50. Manning, B. D.; Cantley, L. C. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem. Soc. Trans. 2003, 31, 573-578. (Pubitemid 36750733)
51. Eder, A. M.; Dominguez, L.; Franke, T. F.; Ashwell, J. D. Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells. J. Biol. Chem. 1998, 273, 28025-28031. (Pubitemid 28496095)
52. Ryves, W. J.; Harwood, A. J. The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle. Prog. Cell Cycle Res. 2003, 5, 489-495.